Peter A. Lankau
Mr. Lankau is the Executive Chairman of Nautilus Neurosciences, Inc. and is the former Chairman and CEO of Logical Therapeutics, Inc..
Prior to Logical, he was the President and Chief Executive Officer, and member of the Board of Directors, of Endo Pharmaceuticals Inc., a publicly traded specialty pharmaceutical company. He also served as the company’s President and Chief Operating Officer and as Senior Vice President, US Commercial Business. While CEO, he lead the company to become an industry leader in pain management, as well as developing its pipeline in pain and supportive care oncology, which included 12 product acquisitions and/or licensing transactions.
Prior to Endo, Mr. Lankau was Vice President, Sales and Marketing for Alpharma, Inc. where he developed the business plan to evolve the company into a specialty and branded pharma company. He began his pharmaceutical career with Rhone-Poulenc Rorer, Inc. (now Sanofi-Aventis Inc) in multiple commercial roles, and was most recently Vice President, Sales-US Pharmaceuticals.
Carolyn E. Green
Carolyn Green was a co-founder of Logical Therapeutics. Previously, Ms. Green was the founding Director of the Office of Enterprise Development at the University of Pittsburgh. During her tenure, she was the architect behind a dozen biotechnology spin-outs stemming from the University's $650 M in annual NIH funding. Ms. Green is a Certified Licensing Professional, and has more than twenty years of management and operating experience.
K. Lea Sewell, MD
A board-certified rheumatologist, Dr. Sewell has more than 7 years of experience, working in the biotechnology industry. She is the former Vice President of Clinical Development at Logical. Prior to joining Logical Therapeutics, Dr. Sewell managed clinical development programs at Isis Pharmaceuticals, Genentech, and Fibrogen and was a clinical investigator at Harvard Medical School.
124 Washington Street, Suite 101
Foxboro, MA 02035